Increasing the dose of the infusion therapy Ocrevus (ocrelizumab) does not provide additional benefit compared with the approved regimen in slowing disability progression for people with relapsing forms of multiple sclerosis (MS) or primary progressive MS. That’s according to final data from two global Phase 3b clinical…
Discussion
One of the hardest parts of living with chronic illness is being misunderstood in moments when I have the least energy to explain myself. With multiple sclerosis (MS) and postural orthostatic tachycardia syndrome (POTS), sometimes my heart rate skyrockets, my body overheats, my energy drops, my nervous system…
Discussion
Raised by a single mom, I always knew I had someone in my corner, encouraging my wildest dreams, while supporting me through my journey with relapsing-remitting multiple sclerosis (MS). For as long as I can remember, I’ve been driven by a desire to challenge myself and embrace new…
Discussion
Novel ring-shaped sugar molecules called cyclodextrins may help promote conditions that support myelin repair in multiple sclerosis (MS) by easing harmful changes in the immune cells that clear away damaged myelin, a new lab study suggests. Researchers found that after taking up myelin debris over time, these immune cells…
Discussion
A Phase 2a clinical trial testing Tiziana Life Sciences‘ experimental intranasal therapy foralumab in people with nonactive secondary progressive multiple sclerosis (SPMS) has begun dosing its final participant. The INFORM-MS trial (NCT06292923) is evaluating the safety, tolerability, and efficacy of foralumab versus a placebo in up…
Get regular updates to your inbox.
